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There are fundamental aspects of the control of metabolic homeostasis that are regulated differently in males and
females. This sex asymmetry represents an evolutionary paradigm for females to resist the loss of energy stores. This
perspective discusses the most fundamental sex differences in metabolic homeostasis, diabetes, and obesity.
Together, the role of genetic sex, the programming effect of testosterone in the prenatal period in males, and the
activational role of sex hormones at puberty produce two different biological systems in males and females that need
to be studied separately. These sex-specific differences in energy homeostasis and metabolic dysfunction represent an
untested source of factors that can be harnessed to develop relevant sex-based therapeutic avenues for diabetes,
metabolic syndrome, and obesity.
Review
Introduction
“This is a man’s, man’s, man’s world but it would be
nothing, nothing without a woman or a girl” is sung by
James Brown in 1966. Regarding biomedical research,
however, it was not until 1993 that the National Institutes
of Health (NIH) Revitalization Act mandated the inclusion
of women in clinical trials, so that the outcome of all
NIH-funded clinical research would generate data that is
relevant to individuals of both sexes. The goal was simple:
Since a primary aim of research is to provide scientific evi-
dence to improve health, it was imperative to determine
whether the therapy being studied differentially affects
men and women. Still, most preclinical researchers avoid
studying female rodents due to the added complexity of
research plans [1], without regard for the consequences of
generating data that is mostly relevant to only half of the
population. NIH Director Francis Collins and Associate
Director for Research on Women’s Health Janine Clayton
finally asked scientists to consider sex in preclinical re-
search, to ensure that women get the same benefit of med-
ical research as men [2]. The NIH recently released a
notice on new rules to promote the study of animals and
cells from both sexes to prevent the overreliance on male
animals in preclinical studies [3].
With regard to preventing metabolic disease, there is
an urgent need to study both sexes. There are fundamen-
tal aspects of metabolic homeostasis that are regulated dif-
ferently in males and females and likely influence both the
development of diabetes and obesity and the response
to pharmacological intervention. This perspective re-
views the most fundamental sex differences in metabolic
homeostasis, diabetes, and obesity, highlights physiological
and genetic mechanisms for these sex differences, and
proposes that they represent foundations for sex-specific
medicine.
Sex asymmetry in energy metabolism and the gametes
Perhaps, the most illuminating sex difference in energy
metabolism lies at the level of the gametes themselves,
the sperm and the egg [4] (Fig. 1). Males produce sperm
that are small, numerous, and highly mobile, but dispos-
able. In contrast, the female produces a small number of
large and immobile eggs. While the male shares only his
genes during conception, the female, by way of the fertil-
ized egg, provides not only the genes but also the source
of energy and the nutrients contained in the cytosol of
the egg for the embryo to develop and thrive. Further,
the sex dimorphism goes deeper with the uniparental in-
heritance of the ultimate cellular energy-producing or-
ganelle, the mitochondria [5]. The female transmits this
critical organelle; the male does not. Thus, from the be-
ginning of reproduction, a major sex asymmetry is
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present, the fact that females’ gametes transmit all
their resources, i.e., their energy stores, their cytosol,
and their mitochondria (Fig. 1). It is also noteworthy
that female mammals bear the costly burden of gesta-
tion and lactation and resist the loss of body energy
stores during prolonged periods of food scarcity so
that the offspring is not affected. In contrast, in male
mammals, energy storage is less an evolutionary strat-
egy. They must mobilize energy stores immediately for
short-term and intense muscle activity related to hunt-
ing and protection needs. This is also observed at the
level of the gametes since spermatozoa are highly mo-
bile cells with a dense mitochondrial network that
must provide ATP promptly to its tail to promote en-
ergy for sperm mobility [6].
What is the basis for this asymmetry in energy metab-
olism at the level of the gametes? Sex differences in the
gametes do not contribute to sex differences in post-
fertilization metabolic phenotypes. However, the sex dif-
ferences in metabolic homeostasis in somatic tissues,
which have evolved to serve female and male differently
as we will discuss below, might also have had an impact
on germ cells to contribute to the sex differences in gam-
etes. Thus, one may speculate that this sex asymmetry in
energy metabolism at the gametes level is a reflection of
the adult sexually differentiated metabolic phenotype that
is the topic of this review.
Females have evolved specific ways to favor adipose
tissue storage
The first observable consequence of this evolutionary para-
digm—that females resist the loss of body energy stores
while males mobilize energy stores promptly—is the distri-
bution of the main energy storage organ, the white adipose
tissue. Over 70 years ago, Prof. Jean Vague, a French phys-
ician from Marseilles, made seminal observations on sex
differences in adipose tissue distribution and noted that “A
woman normally has twice a man’s fat mass… Though she
is as often obese as a man or fatter, she dies less often from
the metabolic complications of obesity” [7]. These initial
observations led to establish the well-known propensity
of women to store adipose tissue in subcutaneous areas
Fig. 1 Sex dimorphism in energy metabolism at the level of the gametes. The male spermatozoa (left) share only their genes. The female, by way of the
fertilized egg (right), provides not only her genes but also the energy stores and the nutrients contained in the cytosol of the egg and the mitochondria
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compared to the preferential visceral fat deposition in
men [8]. These differences can be directly related to
the sex-specific role of fat, since subcutaneous adipo-
cytes are more adapted to long-term storage while vis-
ceral adipocytes are more metabolically active and
sensitive to lipolysis. These sex differences in adipose
storage have been recently and extensively reviewed by
Susan Fried and Debbie Clegg [9, 10]. The sex differ-
ence in adipose storage is not limited to white adipose
depots. In animal models, females have more active
brown adipose tissue than males [11]. Women also seem
to have more brown adipose depots. In a study using
(18)F-fluorodeoxyglucose positron-emission tomographic
and computed tomographic (PET-CT) scans to identify
cervical and thoracic brown adipose tissue, Cypess et al.
found that not only were women twice as likely as men to
have brown adipose tissue signal, they also had a greater
mass of brown adipose tissue with higher metabolic activ-
ity [12]. In fact, there is a higher relative contribution of fat
mass to resting metabolic rate in women that is in part ex-
plained by an increased number of brown adipocytes [13].
The adipose sex dimorphism also extends to the func-
tion of adipocytes. The two major adipokines, leptin and
adiponectin, are characterized by higher circulating levels
in women than men [14, 15]. While some of these differ-
ences are related to the action of sex hormones, in the
case of leptin, the increase in females is apparent before
puberty and remains after menopause [16, 17]. This sug-
gests that factors other than post-pubertal sex hormones
are involved. Some of these factors, like genetic sex or pre-
natal programming by the testicular testosterone surge,
will be discussed below.
Sex differences in energy partitioning and balance
Perhaps as a consequence of these evolutionary paradigms,
a fundamental sex difference exists in the utilization of car-
bohydrates and lipids as fuel sources (Fig. 2). At rest and
during the post-absorptive state, women tend to incorpor-
ate free fatty acids (FFA) into triglyceride (TG) which helps
store fat. In contrast, in these same resting conditions, men
will oxidize circulating FFA [18]. However, when energy re-
quirements increase during exercise, women oxidize a
greater proportion of lipids relative to carbohydrates
[19–21]. In contrast, during exercise, men will prefer-
entially use carbohydrates as a fuel source. Women also
exhibit a greater reliance on lipids as a fuel source at
high altitudes where oxygen is low [22]. In postmeno-
pausal women [23] and ovariectomized female rodents
[24], both of whom exhibit estrogen deficiency, lipid
oxidation decreases, indicating that estrogen plays a
role in this difference. This sex dimorphism in sub-
strate partitioning is dramatically exemplified in mice
lacking the peroxisome proliferator-activated receptor
α (PPARα−/−), the master regulator of fatty acid oxidation.
In male PPARα−/−mice, pharmacologic inhibition of mito-
chondrial fatty acid oxidation caused massive lipid accu-
mulation in the liver. As a result of inhibited energy
production via fatty acid oxidation, there is excessive glu-
cose oxidation leading to death by hypoglycemia [25].
However, this phenotype was observed in only 25 % of fe-
males, suggesting that females can still utilize fatty acids
as an energy source. Further, the metabolic phenotype of
males was prevented by estradiol treatment. Thus, the fe-
male hormone estrogen seems to be a powerful evolution-
ary mechanism by which, in specific circumstances, females
can rely on lipid oxidation as an energy source. This energy
partitioning strategy would provide females with a greater
capacity to spare protein mass during period of food scar-
city, a clear survival advantage [26]. Most importantly, dur-
ing pregnancy, increased lipid oxidation would also spare
circulating glucose away from muscle oxidation in order to
preserve it for the fetal brain.
Another fundamental sex difference in energy balance re-
lates to energy intake. In mammals, males consume more
food than females, which is considered a masculinized be-
havior [27]. Although it is assumed that the increased en-
ergy intake of males supports their higher muscle mass, the
evolutionary survival strategy of male mammals following
food deprivation is still to increase fat stores by increasing
energy intake [28]. Conversely, females reduce loss of fat
stores by decreasing energy expenditure [28]. This latter
mechanism is consistent with females’ ability to resist the
loss of energy stores during periods of food scarcity. The
consequence of these survival strategies is that starvation
has a greater negative impact on males. When animals are
subjected to complete starvation, females have a greater ra-
tio of lipid to protein loss and are more likely to survive
[26, 29]. Anecdotally, the majority of deaths by undernutri-
tion during WWII in Europe were men [30]. Interestingly,
this sex difference in the ability to resist the loss of energy
stores could result from a sex dimorphism of the hypothal-
amic melanocortin system, at least in mice. Indeed, com-
pared to females, male mice exhibit a decreased density of
anorexigenic neuropeptide pro-opiomelanocortin (POMC)
neuronal fibers in the hypothalamic arcuate nucleus, and
decreased POMC gene and protein expression, which is as-
sociated with an increased energy intake [31]. Accordingly,
female rats are more sensitive to the anorectic action of
centrally injected leptin than males [32]. Male rats, how-
ever, are more sensitive to the anorectic action of insulin
injected in the brain [32], an observation that translates to
humans. Indeed, intranasal insulin—which reaches the
brain directly along olfactory perivascular channels—re-
duces body fat in men but not in women [33]. We will
discuss below how some sex dimorphisms in hypothalamic
structure and function can be set by the organizational ef-
fect of the prenatal testicular testosterone surge. Figure 2
summarizes sex differences in energy balance.
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Females favor glucose homeostasis
Compared to men, healthy women have more adipose
mass, more circulating FFA, higher intramyocellular lipid
content, and only two thirds the skeletal muscles mass of
men, all factors that would be predicted to promote insulin
resistance in women. Yet, women are as sensitive to insulin
as men (Fig. 3). In fact, women are resistant to FFA-
induced insulin resistance [34]. When matched for physical
fitness and under hyperinsulinemic, normoglycemic clamp
conditions, whole body insulin sensitivity is 41 % greater in
women as a result of a 47 % greater glucose uptake by fe-
male skeletal muscles [35]. Physical fitness is an important
parameter, and women with lower fitness than men have
decreased insulin sensitivity [36]. Yet, these same women
exhibit comparable glucose disposal to men because of en-
hanced glucose effectiveness. The maintenance of glucose
homeostasis in women is at least partially due to the benefi-
cial effect of a tight physiological window of estrogen con-
centrations between puberty and menopause. Indeed, after
menopause, when serum estrogen concentrations drop,
women become insulin resistant. Similarly, when circulat-
ing estrogen concentration rises to supraphysiological levels
[24], or when powerful synthetic estrogens like oral contra-
ceptives are used [37], insulin resistance develops.
Males are predisposed to diabetes
The prevalence of pre-diabetic syndromes such as im-
paired fasting glucose (IFG) and impaired glucose toler-
ance (IGT) differs by sex, with IFG being more prevalent
in men while IGT is more prevalent in women [38–41].
The reason for these differences is unknown. However,
one can speculate that the smaller muscle mass or phys-
ical fitness in women discussed above [36] would de-
crease insulin-stimulated glucose disposal and account
for the observed higher rate of IGT. There are also sex
differences in diabetes pathophysiology and prevalence.
Type 1 diabetes is the only common autoimmune dis-
ease characterized by a male predominance in popula-
tions of European origin (ratio 1:7) (reviewed in [42]). A
strong male predominance (75 %) is also observed in
ketosis-prone diabetes (also called idiopathic diabetes), a
form of type 2 diabetes with a propensity to acute insu-
lin deficiency [43, 44]. In ketosis-prone diabetes, women
are protected unless they are in a hypoestrogenic state
[43, 45]. Type 2 diabetes prevalence is also marked by a
sex dimorphism. A survey of the global diabetic popula-
tion revealed that the sex difference in the prevalence of
diabetes was reversed depending upon the stage of re-
productive life [46]; that is, there are more diabetic men
Fig. 2 Summary of sex dimorphisms in metabolic homeostasis, diabetes, and obesity. The left panel represents the males and the right panel
the females
Mauvais-Jarvis Biology of Sex Differences  (2015) 6:14 Page 4 of 9
before puberty, while there are more diabetic women
after menopause. Figure 2 summarizes sex differences in
diabetes and pre-diabetes development.
Females are predisposed to obesity and metabolic
syndrome
As discussed above, females tolerate higher levels of body
fat due to a lower amount of abdominal fat. However, they
are at greater risk of obesity due to their increased pro-
pensity to gain fat. In fact, the global prevalence of obesity
is higher in women than in men in all continents [47].
Interestingly, over the last decades, the prevalence of ab-
dominal obesity has increased more in women than in
men in the USA [48]. Today, the prevalence of visceral
obesity associated with metabolic syndrome is two to ten
times higher in women in many countries around the
world [49–51]. This female predisposition to central adi-
posity is observed in many races, across all age groups,
and in both urban and rural areas [50]. Figure 2 summa-
rizes sex differences in the incidence of obesity and meta-
bolic syndrome.
Activational role of gonadal sex hormones after puberty
The major contributors of sex dimorphisms in glucose
and energy homeostasis are the “activational” effects of
estrogens and androgens acting on their receptors after
the onset of puberty. These actions of sex hormones on
metabolic homeostasis and their implication for diabetes
and obesity in males and females have been extensively
described in recent reviews and will not be discussed
here [24, 52]. However, it is important to stress that
non-reproductive organs like the brain and adipose tis-
sue are also sites of androgen and estrogen biosynthesis.
In these tissues, androgens convert to estrogens in both
males and females. Adipose tissue is also a reservoir of
sex steroids that act locally in a paracrine and intracrine
manner (reviewed in [53]). The total sex steroid content
of adipose tissue has been estimated in some studies to
be a hundred times greater than total plasma content
[54]. Steroid fatty acid esters are present in adipose tissue
of both male and female rats [55]. These testosterone es-
ters are long-lived in the blood even after castration and
represent an adipose testosterone reservoir for slow re-
lease (although human adipose tissue steroid ester has not
yet been demonstrated). Further, tissue metabolism or in-
activation of estrogen by the cytosolic enzyme estrogen
sulfotransferase (EST) is also an essential factor in con-
trolling cellular estrogenic action and sex differences in
adipose biology; [56, 57]. Thus, in human adipose tissue
(and in the brain), the local tissue and cellular output of
sex hormone action is more complex than would be pre-












Fig. 3 Proposed mechanism for sexual differentiation of metabolism. Perinatal exposure to testosterone in female rodents and primates
can program multiple tissues involved in metabolic homeostasis. This could lead to a sexual differentiation or masculinization of
metabolic homeostasis
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concentrations in males and females. Therefore, the intra-
crinology of sex hormones in metabolic tissues in adults is
an underestimated but critical aspect of sex differences in
metabolic function that should be considered (Fig. 3).
The organizational role of testosterone surge and the
masculinization of metabolism
In mammals, the effect of sex hormones is not limited
to their “activational” role after puberty. To achieve a
male-specific brain, the differentiated testis produces a
prenatal (in human and nonhuman primates) or neo-
natal (in rodents) testosterone surge that is critical to
masculinize the organism [58]. The programming or
“organizational” role of testosterone in perinatal life is
paramount. If the brain is exposed to testosterone either
from its own testes in males or from an exogenous
source in females, it will be masculinized [59–64]. Ex-
tensive evidence links sexually dimorphic aspects of
physiology to differences in programming by this early tes-
tosterone surge in males that programs the organization
of neural circuits permissive to the activation of male be-
havior at puberty [59–64]. It is believed that perinatal tes-
tosterone exposure causes the hypothalamus to change its
structure and function, leading to major sex differences in
sexual behavior and reproduction. Thus, like the hypothal-
amic control of reproduction, the hypothalamic control of
energy homeostasis could be programmed or defeminized
as well as masculinized by the perinatal testicular testos-
terone surge in males. In fact, evidence suggests that this
is the case for the hypothalamic melanocortin system, at
least in mice [31, 65, 66]. Indeed, when female mice are
neonatally androgenized with testosterone (as males are
normally by the testicular testosterone surge), these
neonatally androgenized females exhibit a masculinized
POMC neuronal architecture in the hypothalamic arcu-
ate nucleus in adults as is observed in littermate adult
males [31]. Further, a transient perinatal androgen ex-
cess in female rodents, nonhuman primates, and even
humans can masculinize their metabolism and repro-
gram their genetic predisposition to obesity and metabolic
syndrome in adulthood without any alteration in adult sex
hormone levels [31, 65–71]. This masculinization involves
all the sexually dimorphic parameters discussed above such
as adipose tissue distribution, adipocyte size, adipocytokine
concentrations, insulin sensitivity, energy intake, and even
some aspects of sympathetic tone to adipose tissue
[31, 65, 66]. Interestingly, such a masculinization also
involves an increase in lean mass of skeletal and car-
diac muscles, bone, and kidney [41]. Therefore, the
perinatal testosterone surge could program the defemini-
zation and masculinization or a sexual differentiation of
metabolic homeostasis (Fig. 3). Further studies are needed
to elucidate this critical issue.
Role of sex chromosomes
Finally, there is the influence of the genetic sex. First,
there is what is called the direct sex chromosome effect
of X and Y genes that produce differences in cellular
function of XX females and XY male cells. For example,
the Y chromosome is known to accelerate cellular glu-
cose metabolism and growth [72]. In addition, XY em-
bryos show higher metabolic rates than XX embryos and
develop faster [73]. Further, recent evidence suggests
that the X and Y chromosomes program sex differences
in metabolic regulation [74]. Reue and coworkers used a
mouse model in which the gonadal sex (Sry gene) and
the chromosomal sex (complement of sex chromo-
somes) are dissociated because Sry is deleted from the Y
chromosome and inserted as a transgene into an auto-
some in both XX (XXSry) and XY (XY−Sry) genotypes.
These mice produce offspring that include XX and XY
males (mice that have Sry and develop testes) and XX
and XY− females (mice that lack Sry and develop ovar-
ies). This model system is unique in that it permits
testing the independent contribution of Sry, which is
mediated by testosterone secretion, vs. non-Sry sex
chromosome genes (complement of sex-linked genes),
which have been untested in previous metabolic stud-
ies. Using this model, Chen et al. showed that male
and female XX mice exhibit increased fat depots and
increased food intake compared to XY mice. When
placed on a high-fat diet, XX mice gained adiposity
and developed fatty liver and insulin resistance regardless
of their original gonadal sex. Interestingly, XX mice had lar-
ger subcutaneous inguinal adipose tissue depots, whereas
XY mice had larger gonadal fat pads, suggesting that the
number of X chromosomes contributes to sex differences
in fat distribution. In another strain of mice, the same au-
thors showed a role for the Y chromosome in metabolism
independent of testes and gonadal hormones [75]. There-
fore, both X and Y chromosomes affect adiposity. Consist-
ent with this possibility, neonatally androgenized female
mice develop many of the features of metabolic syndrome
[31, 65, 66]. These features include increased food intake
and lean mass, visceral adiposity with enlarged adipocytes,
hypoadiponectinemia, decreased osteocalcin activity, insulin
resistance, pre-diabetes, and hypertension. In contrast, lit-
termate male mice also exposed neonatally to testosterone
develop a mild metabolic phenotype with decreased lean
mass and food intake and SC adiposity without cardio-
metabolic alterations [76]. Therefore, neonatal testos-
terone exposure has programmed a different phenotype
in male and female adults possibly in relation to their
sex-specific genetic background. However, in this model,
genetic sex is confounded with hormonal sex. Indeed,
males had already been masculinized by their own neo-
natal testosterone surge, and they may have responded
differently to injected testosterone.
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Conclusions
Until recently, most clinical research has been carried out
under the assumption that the male can fulfill the function
of the representative of the human species. Today, basic
research using animal models is still performed mostly on
males. However, as discussed in this perspective, the role
of sex is a fundamental issue in the incidence and evolu-
tion of diabetes, obesity, and metabolic syndrome. The
fact that many investigators avoid studying females to
keep the experimental protocol more simple is in itself ad-
mission of sex differences. Together, the role of genetic
sex, the organizational role of testosterone in the prenatal
period, and the activational role of sex hormones at pu-
berty define two different genetic and biological systems
in male and females (Fig. 4). This “sexome,” as coined by
Art Arnold and which is the sum of all sex-specific influ-
ences on gene networks and cellular systems [77], pro-
duces the emerging phenotypical sex differences in body
composition and the mechanisms of energy homeostasis.
Therefore, we need to study the system biology of each
sex globally in order to have an appreciation of the sex-
specific aggregate behavior of the genome. Indeed, tran-
scriptome analysis of liver, muscle, and adipose tissues of
mice reveals sex differences in expression of over half
these genes [78]. Further, a metabolomic profiling of sex-
specific differences in serum metabolite revealed major
concentration differences between males and females for
over three quarters of the metabolites studied [79]. Not
surprisingly and as a result, there is a sex-specific response
to anti-diabetic drugs in patients with type 2 diabetes. For
example, males responded better to sulfonylurea treat-
ment compared with women [80] and responders to rosi-
glitazone were more likely to be females than males [81].
Since most sex differences related to diabetes and obes-
ity in humans are also found in animal models, both sexes
should be studied to elucidate the determinants of these
fundamental biological sex differences from genes to hor-
mones. This is a necessary step toward personalized,
sex-specific medicine. In fact, there is a clear economic
advantage in considering both males and females early
in preclinical and translational research. Indeed, the
identification of sex-specific differences in metabolic
function and metabolic disease incidence and progres-
sion would provide an untapped source of factors that
can be studied to prevent metabolic dysfunction and in-
form clinical trials. This knowledge will allow the devel-
opment of relevant sex-based therapeutic avenues for
diabetes, metabolic syndrome and obesity.
Fig. 4 The male and female biological systems. The combined influence of the genetic sex, the organizational effect of the testosterone surge,
and the activational role of sex hormones at puberty define two different genetic and biological systems in males and females
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